Accounts Receivable	6 Months Ended
	Jun. 30, 2022
Receivables [Abstract]
Accounts Receivable	Accounts Receivable    As of June 30, 2022 and December 31, 2021, the Company had accounts receivable of $2.3 million and $13.3 million respectively, which primarily relates to royalty revenue from net sales of NARCAN®.